Patients with type 2 diabetes benefit from primary care-based disease management: A propensity score matched survival time analysis

Population Health Management

Volumn 15, Issue 4, 2012, Pages 241-247

  Drabik, Anna ^a   Büscher, Guido ^a   Thomas, Karsten ^a   Graf, Christian ^b   Müller, Dirk ^a   Stock, Stephanie ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b BARMER GEK Sickness Fund   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG COST; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH STATUS; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROPENSITY SCORE; SOCIAL STATUS; SURVIVAL TIME;

DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PRIMARY HEALTH CARE; PROPENSITY SCORE; RETROSPECTIVE STUDIES;

EID: 84865203091     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0063     Document Type: Article

References (31)

1. Hauner H. Epidemiology and costs of diabetes mellitus in Germany. Dtsch Med Wochenschr. 2005;130:S64-S65.
2. Jönsson B; CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45:S5-S12.
3. Statistisches Bundesamt. Gesundheit. Todesursachen in Deutschland 2008. Fachserie 12, Reihe 4. Wiesbaden, Germany: Bestatis; 2010.
4. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145-1151.
5. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet. 2007;369:750-756.
6. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: Cohort study. BMJ. 2008;337:a236.
7. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation. 2009;119:1728-1735.
8. Joos S, Rosemann T, Heiderhoff M, et al. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct-astudy protocol.BMCPublic Health. 2005;5:99.
9. Miksch A, Laux G, Ose D, et al. Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care. 2010;16:49-54.
10. Ose D, Wensing M, Szecsenyi J, Joos S, Hermann K, Miksch A. Impact of primary care-based disease management on the health related quality of life in patients with type 2 diabetes and comorbidity. Diabetes Care. 2009;32:1594-1596.
11. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A. German diabetes disease management programs are appropriate for restructuring Careaccording to the chronic Caremodel. Diabetes Care. 2008;31:1150-1154.
12. Kü mler T, Gislason GH, Køber L, Torp-Pedersen C. Diabetes is an independent predictor of survival 17 years after myocardial infarction: Follow-up of the TRACE registry. Cardiovasc Diabetol. 2010;9:22.
13. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
14. Linden A, Adams JL, Roberts N. Using propensity scores to construct comparable control groups for disease management program evaluation. Dis Manag Health Out. 2005;13: 107-115.
15. Parsons LS. Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. Cary, NC. SAS Institute, Inc; 2001:214-226.
16. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med. 2007;26:734-753.
17. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134:1128-1135.
18. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries'costs of Carein the last year of life. Health Aff (Millwood). 2001;20:188-195.
19. Polder JJ, Barendregt JJ, van Oers H. Health Carecosts in the last year of life-The Dutch experience. Soc Sci Med. 2006; 63:1720-1731.
20. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: The matching package for R. J Stat Softw. J Stat Software. 2011;42:1-52.
21. Schäfer I, Kü ver C, Gedrose B, et al. Selection effects may account for better outcomes of the German disease management program for type 2 diabetes. BMC Health Serv Res. 2010;10:351.
22. Kassenärztliche Vereinigung Nordrhein. Disease-Management-Programme in Nordrhein. Available at: http://www .kvno.de/downloads/quali/qualbe-dmp09. pdf. Accessed August 29, 2011.
23. Thiebaud P, Demand M, Wolf SA, Alipuria LL, Ye Q, Gutierrez PR. Impact of disease management on utilization and adherence with drugs and tests: The case of diabetes treatment in the Florida: A Healthy State (FAHS) program. Diabetes Care. 2008;31:1717-1722.
24. Stock S, Drabik A, Bü scher G, et al. German diabetes management programs improve quality of Careand curb costs. Health Aff (Millwood). 2010;29:2197-2205.
25. Encinosa WE, Bernard D, Dor A. Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes. Adv Health Econ Health Serv Res. 2010;22:151-173.
26. Anaya JP, Rivera JO, Lawson K, Garcia J, Luna J, Oritz M. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health-Syst Pharm. 2008;65:1841-1845.
27. Stephens JM, Botteman MF, Hay JW. Economic impact of antidiabetic medications and glycemic control on managed Careorganizations: A review of the literature. J Manag CarePharm. 2006;12:130-142.
28. Sidorov J, Girolami S, Shull R, Lawton N, Tomcavage J, Harris R. Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care. 2002;25:684-689.
29. Graf C, Elkeles T, Kirschner W. Gibt es einen Selektionsbias im DMP Diabetes? Ergebnisse einer Versichertenbefragung von DMP-Teilnehmern und nichtteilnehmenden Diabetikern. Z Allg Med. 2009;85:74-81.
30. Rosenbaum PR. Observational Studies. 2nd ed. New York: Springer; 2002.
31. Linden A. Estimating the effect of regression to the mean in health management programs. Dis Manag Health Out. 2007; 15:7-12.